Skip to content
healthcare.dev

ANKTIVA

NDC 81481-803, nogapendekin alfa inbakicept-pmln, solution, from Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc..

Product NDC
81481-803
Status
Listed
Labeler
Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc.
Dosage form
SOLUTION
Route
INTRAVESICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761336
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/81481-803 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NOGAPENDEKIN ALFA INBAKICEPT-PMLN400 ug/.4mL

Pharmacologic classes

Interleukin-15 Receptor Agonist [EPC]; Interleukin-15 Receptor Agonists [MoA]

Package NDCNDC-11Package
81481-803-01814810803011 VIAL, GLASS in 1 BOX (81481-803-01) / .4 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/eae31db8-3e7a-d9e0-708d-74419d1b50ff
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=81481-803

Use it

Look up 81481-803 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/81481-803 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 81481-803. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.